UROLOGIC NEOPLASMS
Clinical trials for UROLOGIC NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new UROLOGIC NEOPLASMS trials appear
Sign up with your email to follow new studies for UROLOGIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental drug combo shows promise for Tough-to-Treat bladder cancer
Disease control TerminatedThis study tested an experimental drug called enfortumab vedotin, alone or with other cancer drugs, in 348 people with advanced bladder or urinary tract cancer. The goal was to see if the drug could shrink tumors and control the disease. The trial was terminated early, so the ful…
Matched conditions: UROLOGIC NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 22, 2026 11:59 UTC
-
Kidney cancer combo trial halted early – what we know
Disease control TerminatedThis study tested a new drug (NKT2152) combined with two other medicines (palbociclib and sasanlimab) in people with advanced clear cell kidney cancer that had worsened after prior treatments. The goal was to see if the combination was safe and could shrink tumors. The trial was …
Matched conditions: UROLOGIC NEOPLASMS
Phase: PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Jun 18, 2026 11:49 UTC